---

Transaction Summary

• Revenue has increased rapidly to $59M run rate and 26% YoY growth
• Completed IPO in January 2015 raising $78M
• Well-positioned as an acquisition target; significant premiums paid as revenues approach ~$100M

• Plymouth, MN
• NASDAQ: ENTL


• Contact:
  Guido J. Neels
  
• www.entellusmedical.com
• IPO
• Acquisition
• Acquired by: Stryker
• Exit date: February 28, 2018
• 

Related News

• Centers for Medicare/Medicaid Services Establishes Coding and Payment for Eustachian Tube Balloon
• Entellus Medical Inc. Completes Series E Financing Totaling $35 Million
• Entellus Medical Announces Presentation of Positive Clinical Results in Pediatric Patients
• Study Shows That Employee Chronic Sinusitis Sufferers and Their Employers Benefit from Balloon Dilation of Sinus Drainage Pathways